Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation

Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation

Glibenclamide (GB), oral antidiabetic sulfonylurea, is used in the management of diabetes mellitus type II. It suffers from low bioavailability due to low water solubility. This work aimed to enhance the dissolution of GB by formulating the drug as a proniosomes which then improves the pharmacologic...

Full description

Bibliographic Details
Main Authors:	Doaa Alshora, Mohamed Ibrahim, Nouf Alanazi, Malak Alowyid, Zainab Ali Alnakhli, Noura Mohammed Alshiban, Saleh Maodaa, Nouf M. Alyami, Ibrahim Alotaibi
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Glibenclamide Proniosomes UPLC method Pharmacodynamics study Dissolution enhancement
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423003250

Similar Items

Oral administration of proniosomal glibenclamide formulation protects testicular tissue from hyperglycemia fluctuations and ROS via Nrf2/HO-1 pathway
by: Nouf M. Alyami, et al.
Published: (2024-05-01)

Optimization and Validation of Sensitive UPLC-PDA Method for Simultaneous Determination of Thymoquinone and Glibenclamide in SNEDDs Formulations Using Response Surface Methodology
by: Doaa Hasan Alshora, et al.
Published: (2023-11-01)

Correlation of Solubility Thermodynamics of Glibenclamide with Recrystallization and In Vitro Release Profile
by: Ravi Maharjan, et al.
Published: (2022-02-01)

CO2 utilization as a gas antisolvent in the production of glibenclamide nanoparticles, glibenclamide-HPMC, and glibenclamide-PVP composites
by: Seyed Ali Sajadian, et al.
Published: (2024-06-01)

EFFECT OF HYDROXYETHYLCELLULOSE ON THE RELEASE OF GLIBENCLAMIDE FROM SUSTAINED RELEASE TABLETS
by: S. V. Trofimov
Published: (2019-01-01)

Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization
by: Rana M.F. Sammour, et al.
Published: (2019-07-01)

Development of Proniosome Gel Formulation for CHIKV Infection
by: Ayça Altay Benetti, et al.
Published: (2024-07-01)

Proniosomes: A pro vesicular system in ocular drug delivery
by: Neha Kandpal, et al.
Published: (2023-12-01)

Doxycycline Proniosomal Gel as Local Drug Delivery System in Periodontal Disease: A Vitro Study
by: Dhawal Rajendra Mody, et al.
Published: (2024-12-01)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
by: Rajan Rajabalaya, et al.
Published: (2016-08-01)

Chlorogenic acid loaded niosomes and proniosomes: in vitro antioxidant and antibacterial activities with efficacy in wound healing
by: Hemangi Ramesh Trivedi, et al.
Published: (2023-06-01)

Optimization of Glibenclamide Loaded Thermoresponsive SNEDDS Using Design of Experiment Approach: Paving the Way to Enhance Pharmaceutical Applicability
by: Abdelrahman Y. Sherif, et al.
Published: (2024-10-01)

A Robust and Reliable UPLC Method for the Simultaneous Quantification of Rosuvastatin Calcium, Glibenclamide, and Candesartan Cilexetil
by: Mohamed Abbas Ibrahim, et al.
Published: (2024-04-01)

Glibenclamide therapy: pros and cons
by: Olga Konstantinovna Vikulova, et al.
Published: (2011-09-01)

Development, In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity
by: Dibyalochan Mohanty, et al.
Published: (2022-04-01)

The effects of glibenclamide on thyroid function tests in type 2 diabetic patients
by: Marwan M. Merkhan
Published: (2013-12-01)

Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation
by: Sadek Ahmed, et al.
Published: (2025-06-01)

Effect of Glibenclamide and Tomato lycopene extract on some biochemical parameters in serum of alloxan Induced diabetic rabbits
by: Ayhan R. Mahmood, et al.
Published: (2015-09-01)

Eeffect of the hydroalcolic Lavandula stoechas L. extract in Comparison Glibenclamide on blood glucose in streptozotocin induced diabetic male rats
by: zahra abolghasemi, et al.
Published: (2017-05-01)

Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice
by: Wandee Rungseevijitprapa, et al.
Published: (2021-12-01)

Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant
by: Alfonso Galderisi, et al.
Published: (2023-03-01)

Bioavailability and Antihyperglycemic Effect of Four Glibenclamide Tablets: A Comparative Study
by: Abdelkarim M. Abdelkarim, et al.
Published: (2023-11-01)

Effects of glibenclamide and troxerutin on the sperm parameters and histopathological changes of testis in streptozotocin-induced diabetic male rats: An experimental study
by: Aynaz Shokri, et al.
Published: (2023-02-01)

Effects of glibenclamide and metformin on serum uric acid level in patients with type II diabetes mellitus
by: Najlaa Saadi Ismail
Published: (2011-06-01)

Proniosomal Gel for Topical Delivery of Rutin: Preparation, Physicochemical Characterization and In Vitro Toxicological Profile Using 3D Reconstructed Human Epidermis Tissue and 2D Cells
by: Iulia Pinzaru, et al.
Published: (2021-01-01)

Case report: Fatal cerebral herniation caused by hypoglycemic due to mistaking glibenclamide in children
by: Chunlan Song, et al.
Published: (2023-03-01)

Evaluation of serum pro/anti-angiogenic biomarkers in hyperglycemic rats treated with Securigera securidaca seeds, alone and in combination with Glibenclamide
by: Elham Bahreini, et al.
Published: (2024-03-01)

The study of offspring and mothers with gestational diabetes treated with metformin or glibenclamide in a randomized controlled trial after 9 years
by: Praveen George Paul, et al.
Published: (2023-01-01)

Fabrication of Anti-HSV-1 Curcumin Stabilized Nanostructured Proniosomal Gel: Molecular Docking Studies on Thymidine Kinase Proteins
by: Shady M. Abd El-Halim, et al.
Published: (2020-02-01)

Chitosan-Based Delivery Systems Loaded with Glibenclamide and Lipoic Acid: Formulation, Characterization, and Kinetic Release Studies
by: Luminita-Georgeta Confederat, et al.
Published: (2020-10-01)

Intranasal Mucoadhesive In Situ Gel of Glibenclamide-Loaded Bilosomes for Enhanced Therapeutic Drug Delivery to the Brain
by: Meenakshi Tripathi, et al.
Published: (2025-02-01)

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation
by: Marina Saresella, et al.
Published: (2023-12-01)

Sensitivity of Leishmania spp. to Glibenclamide and 4-Aminopiridine: A Tool for the Study of Drug Resistance Development
by: Alicia Ponte-Sucre, et al.
Published: (1997-09-01)

Interchangeability of glibenclamide-containing drugs
by: G. I. Gorodetskaya, et al.
Published: (2018-02-01)

Glibenclamide Increases Nitric Oxide Levels and Decreases Oxidative Stress in an In Vitro Model of Preeclampsia
by: Priscila Rezeck Nunes, et al.
Published: (2022-08-01)

Glibenclamide ameliorates the expression of neurotrophic factors in sevoflurane anaesthesia-induced oxidative stress and cognitive impairment in hippocampal neurons of old rats
by: Ma Yan, et al.
Published: (2021-12-01)

Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer
by: Shaimaa Hamza, et al.
Published: (2024-02-01)

Revisiting the nature and pharmacodynamics of tacrolimus metabolites
by: Rudy Mevizou, et al.
Published: (2024-11-01)

Validation and development of RP-HPLC method for quantification of glibenclamide in rat plasma and its application to pharmacokinetic studies in wistar rats
by: Khalid Bashir Mir, et al.
Published: (2023-11-01)

Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
by: Marianne Berdugo, et al.
Published: (2021-07-01)